Table 3. Antimicrobial resistance among 600 methicillin-resistant Staphylococcus aureus isolates, Rio de Janeiro, Brazil, 2014–2017*.
| Lineage | Total | No. multidrug-resistant isolates, % |
|---|---|---|
| CC5-SCCmecII | 245 | 119 (48.6)† |
| CC5-SCCmecIV | 137 | 6 (4.4) |
| CC30-SCCmecIV | 109 | 0 |
| CC1-SCCmecIV | 79 | 13 (16.5) |
| CC30-SCCmecII | 8 | 3 (37.5) |
| CC8-SCCmecIII | 7 | 7 (100.0) |
| CC45-SCCmecIV | 5 | 0 |
| CC45-SCCmecII | 4 | 2 (50.0) |
| CC8-SCCmecIV | 4 | 0 |
| CC188-SCCmecIV | 1 | 0 |
| CC22-SCCmecIV | 1 | 0 |
*Multidrug-resistant defined as an isolate carrying >4 additional antimicrobial resistance traits to non–β-lactam antimicrobial drugs. †p<0.01 by Pearson χ2 test.